title: Differences in hemodynamic parameters and exercise capacity between patients with pulmonary arterial hypertension and chronic heart failure.
abstract: BACKGROUND
  Although pulmonary arterial hypertension (PAH) and chronic heart failure (CHF) lead to exercise limitation, their pathophysiology is different. Our objective was to evaluate, using right heart catheterization and cardiopulmonary exercise testing, the difference in hemodynamic parameters and exercise capacity between PAH and CHF, which have the same subjective symptoms.
  
  
  METHODS
  We studied 20 PAH (mean pulmonary artery pressure: 36 ± 10 mmHg, all . 25 mmHg) and 20 CHF (ejection fraction: 35 ± 10%, all < 40%) patients who underwent both cardiopulmonary exercise testing and right heart catheterization. All patients were in New York Heart Association functional class II or III.
  
  
  RESULTS
  Peak oxygen uptake (VO(2)) was lower for PAH patients than for CHF patients (11.7 ± 3.2 mL·kg(-1)·min(-1) vs 14.5 ± 4.6 mL·kg(-1)·min(-1), P = .03), while the slope of ventilation to carbon dioxide production ratio (VE/VCO(2)) was higher for PAH patients than for CHF patients (41.0 ± 12.7 vs 28.0 ± 9.0, P = .001), despite the similarity in their New York Heart Association functional class. Peak VO(2) and VE/VCO(2) correlated with cardiac index for both groups. An important finding was that peak VO(2) correlated with pulmonary vascular resistance for PAH patients (r = 20.46, P = .04) but not for CHF patients (r = 0.33, P = .15). Furthermore, peak VO(2) correlated with pulmonary capillary wedge pressure for CHF patients (r = 20.47, P = .03) but not for PAH patients (r = 0.17, P = .47), while the VE/VCO(2) slope correlated with pulmonary capillary wedge pressure (r = 0.67, P = .002) but not with pulmonary vascular resistance (r = 0.12, P = .63) for CHF patients.
  
  
  CONCLUSIONS
  Peak VO(2) and VE/VCO(2) slope were worse for PAH patients than for CHF patients despite the similar subjective symptoms. This difference might be explained by an altered hemodynamic status.
authors.affiliation: Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
authors.forename: Ryo
authors.initials: R
authors.lastname: Nishio
authors.forename: Hidekazu
authors.initials: H
authors.lastname: Tanaka
authors.forename: Yasunori
authors.initials: Y
authors.lastname: Tsuboi
authors.forename: Hiroto
authors.initials: H
authors.lastname: Kinutani
authors.forename: Yu
authors.initials: Y
authors.lastname: Taniguchi
authors.forename: Mayumi
authors.initials: M
authors.lastname: Shigeru
authors.forename: Ryuji
authors.initials: R
authors.lastname: Toh
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Miura
authors.forename: Yoshitada
authors.initials: Y
authors.lastname: Sakai
authors.forename: Noriaki
authors.initials: N
authors.lastname: Emoto
authors.forename: Hiroya
authors.initials: H
authors.lastname: Kawai
authors.forename: Ken-ichi
authors.initials: K
authors.lastname: Hirata
mesh_terms: D000328:Adult; D000368:Aged; D006328:Cardiac Catheterization / Q000379:methods*; D002908:Chronic Disease; D005080:Exercise Test / Q000379:methods*; D017079:Exercise Tolerance / Q000502:physiology*; D065627:Familial Primary Pulmonary Hypertension; D005260:Female; D006333:Heart Failure / Q000503:physiopathology*; D006439:Hemodynamics; D006801:Humans; D006976:Hypertension, Pulmonary / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption / Q000502:physiology*